FundedIQ

Recently Funded Biotechnology Startups in Menlo Park

Updated Sep 2026

FundedIQ tracks 27 funded Biotechnology startups in Menlo Park, with their funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Biotechnology startup funding landscape in Menlo Park, along with the 27 most recently funded Biotechnology startups in Menlo Park.

Biotechnology startups in Menlo Park closed 13 funding rounds over the last 24 months, 6 of them in the last 12 months, and raised $650M in disclosed capital. The median disclosed round is $21M, with the middle half of rounds falling between $12M and $48M.

Capital in this pocket of Biotechnology leans toward late stage maturity. The presence of institutional backers indicates a preference for proven science over raw speculation. Approaching these firms means engaging with entities that have already cleared significant technical hurdles. This concentration of established funding makes the segment a reliable target for high value partnerships.

Biotechnology funded startup statistics in Menlo Park

Funded Biotechnology startups in Menlo Park
27
tracked in the database
Funding rounds, last 12 months
6
13 over 24 months
Disclosed capital raised, 24 months
$650M
10 of 13 rounds disclosed an amount
Median round size
$21M
middle half $12M to $48M

Most recent funding round on record: Jun 2026.

27 most recently funded Biotechnology startups in Menlo Park

27 shown

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

E
Emmecell
Menlo Park, United States · Biotechnology
Emmecell is a biotechnology company that provides developing cell-based therapies.
Series Unknown ·
Undisclosed
A
Menlo Park, United States · Biotechnology
AN2 Therapeutics, Inc. is a biopharmaceutical company that operates globally and is situated in California.…
Series Unknown ·
$40M
F
Menlo Park, United States · Biotechnology
Forum Markets is a clinical-stage biotechnology company focused on the development of novel drugs that…
Series Unknown ·
$10M
A
Menlo Park, United States · Biotechnology
Abram’s is a novel diagnostic platform for diagnosis and characterization of coagulation-related disorders,…
Series A ·
$12M
A
Menlo Park, United States · Biotechnology
Antheia focuses on creating biosynthetic key starting materials (KSMs) and active pharmaceutical ingredients…
Series C ·
$24M
T
Menlo Park, United States · Biotechnology
Tivic Health is a company that specializes in bioelectronic therapeutics. They create medical devices that…
Series Unknown ·
$18M
1
Menlo Park, United States · Biotechnology
180 Life Sciences Corp. is a biotechnology company in the clinical stage, specializing in creating innovative…
Series Unknown ·
$425M
M
MedaSystems
Menlo Park, United States · Biotechnology
MedaSystems simplifies the process of collaboration between life science companies and healthcare providers…
Seed ·
Undisclosed
P
Menlo Park, United States · Biotechnology
Personalis combines both the technology of sequencing and interpretation, with an extensive history of…
Series Unknown ·
$50M
I
Menlo Park, United States · Biotechnology
IncellDx is a company specializing in molecular diagnostics that is committed to transforming healthcare by…
Series Unknown ·
$500k
B
Menlo Park, United States · Biotechnology
BillionToOne is a precision diagnostics company that uses technology to accurately count DNA molecules at a…
Series D ·
$130M
A
Menlo Park, United States · Biotechnology
Adverum Biotechnologies is a clinical-stage company that aims to establish gene therapy as a new standard of…
Series Unknown ·
$128M
O
Menlo Park, United States · Biotechnology
Octave, a developer specializing in clinical platforms, aims to revolutionize multiple sclerosis care through…
Series Unknown ·
$40M
T
Menlo Park, United States · Biotechnology
TrueBinding is a startup that specializes in developing biotherapeutic molecules for treating diseases with…
Series Unknown ·
$58M
V
Menlo Park, United States · Biotechnology
Vortex Biosciences is an oncology diagnostics company that integrates cancer biology, microfluidic…
Series Unknown ·
$4.1M
I
Invenio Imaging
Menlo Park, United States · Biotechnology
INVENIO IMAGING, Inc. is a privately held corporation founded in 2012 based on the research of Prof. Sunney…
Series Unknown ·
Undisclosed
H
Menlo Park, United States · Biotechnology
A data-driven biopharma business called Hexagon Bio is creating focused small molecule therapies. To find…
Series B ·
$77M
S
Menlo Park, United States · Biotechnology
A business called Synthekine is creating modified cytokine therapies for treating diseases. The business…
Series C ·
$100M
3
Menlo Park, United States · Biotechnology
Founded in 2017, 3T Biosciences is an immunotherapy company headquartered in Menlo Park, California.
Series A ·
$40M
A
Menlo Park, United States · Biotechnology
Alladapt Immunotherapeutics is a secretly held biopharmaceutical organization creating solution therapeutics…
Venture - Series Unknown ·
$119M
I
Menlo Park, United States · Biotechnology
Ionpath is a developer of an ion beam imaging technology used to provide analysis of tissue biopsies. Its…
Corporate Round ·
Undisclosed
A
Menlo Park, United States · Biotechnology
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation. The company…
Series C ·
$60M
C
Menlo Park, United States · Biotechnology
Calysta Energy (www.calystaenergy.com), Menlo Park, CA., is developing a new biological gas-to-liquids™…
Series D ·
$39M
D
Menlo Park, United States · Biotechnology
​Founded in 2013, DiCE Molecules develops a transformative platform for the discovery of novel small…
Series C ·
$60M
S
Menlo Park, United States · Biotechnology
Strateos automates chemistry, biology, and tissue analysis into closed-loop robotic labs that accelerate drug…
·
$56M
R
Menlo Park, United States · Biotechnology
Revelation Biosciences develops immunologic therapeutics and diagnostics designed to make the world a…
Series A ·
$9.1M
G
Menlo Park, United States · Biotechnology
Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer…
·
$390M

Funding stages of funded Biotechnology startups in Menlo Park

How the last 24 months of funding rounds for funded Biotechnology startups in Menlo Park break down by stage.

Stage
Rounds, last 24 months

A further 9 rounds in this period were announced without a stage label and are not ranked above.

About the FundedIQ Biotechnology startup funding data in Menlo Park

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 27 funded Biotechnology startups in Menlo Park currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (3 of 13 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Biotechnology startups in Menlo Park is dated Jun 2026.

The table above shows the 27 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Biotechnology startups are there in Menlo Park?

FundedIQ tracks 27 funded Biotechnology startups in Menlo Park. This page lists the 27 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Biotechnology startups in Menlo Park raised?

Biotechnology startups in Menlo Park tracked by FundedIQ have raised $650M in disclosed capital across 13 funding rounds over the last 24 months, including 6 rounds in the last 12 months. 10 of those 13 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

What is a typical funding round size for Biotechnology startups in Menlo Park?

The median disclosed round over the last 24 months is $21M, and the middle half of rounds fall between $12M and $48M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

What is the most common funding stage for Biotechnology startups in Menlo Park?

Series C is the most common labelled stage, with 2 rounds in the last 24 months, ahead of Seed (1) and Series A (1). A further 9 rounds were announced without a stage label and are not counted here.

How often is the Biotechnology startup funding data in Menlo Park updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Biotechnology startups in Menlo Park is dated Jun 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.